Carbamazepine
Product Images NDC 68788-9812

2 FDA label images from Preferred Pharmaceuticals, Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 68788-9812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (B387be7e E619 46b5 A7cc 2fcc0484e30a 01)

Structure (B387be7e E619 46b5 A7cc 2fcc0484e30a 01)
Chemical structure of carbamazepine showing a dibenzazepine framework with an amide group attached to the nitrogen atom in the central ring.*
FDA Label Image

Carbemazepine Tablets, 200mg (B387be7e E619 46b5 A7cc 2fcc0484e30a 02)

Carbemazepine Tablets, 200mg (B387be7e E619 46b5 A7cc 2fcc0484e30a 02)
Carbamazepine Tablets, 200mg, generic for Tegretal, label from Preferred Pharmaceuticals, Inc. The label shows the active ingredient strength as 200mg per tablet. Directions for use are in English and Spanish, instructing to use as directed by a doctor and to take the tablets every specified number of hours. Manufacturer is listed as Taro Pharmaceuticals Industries Ltd., Haifa Bay, Israel. The label includes storage instructions and caution about federal law prohibiting transfer of the drug to others.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.